NEW YORK (GenomeWeb News) – Toronto-based Spectral Diagnostics said today it will provide Bio-Rad Pasteur with single chain Troponin I reagents under a license and supply agreement.
 
Spectral CEO Paul Walker said the “consistent revenue stream” from the agreement will generate capital the company needs to commercialize its FDA-approved endotoxemia assay, which also tests for the subsequent risk of sepsis.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.